Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defining long-term macrolide maintenance therapy in COPD
2019-004178-24Phase 4Active
- Sponsor
- Amphia Ziekenhuis
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azithromycin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Amphia Ziekenhuis. Primary endpoint: Time to first exacerbation. Started Jun 2020; status: active.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2019-004178-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004178-24.